Blue Edge Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.53M Buy
18,533
+2,029
+12% +$473K 0.6% 45
2025
Q4
$3.42M Buy
16,504
+149
+0.9% +$29.5K 0.46% 54
2025
Q3
$3.03M Hold
16,355
0.43% 54
2025
Q2
$2.5M Sell
16,355
-21
-0.1% -$3.23K 0.37% 55
2025
Q1
$2.72M Buy
16,376
+4
+0% +$626 0.44% 50
2024
Q4
$2.37M Hold
16,372
0.37% 54
2024
Q3
$2.65M Hold
16,372
0.41% 54
2024
Q2
$2.39M Buy
16,372
+24
+0.1% +$3.57K 0.4% 59
2024
Q1
$2.59M Sell
16,348
-10,840
-40% -$1.73M 0.43% 58
2023
Q4
$4.26M Buy
27,188
+343
+1% +$52.6K 0.8% 34
2023
Q3
$4.18M Buy
26,845
+31
+0.1% +$5.12K 0.88% 35
2023
Q2
$4.44M Buy
26,814
+50
+0.2% +$8.07K 0.89% 32
2023
Q1
$4.15M Buy
26,764
+377
+1% +$60.9K 0.9% 35
2022
Q4
$4.66M Buy
26,387
+21
+0.1% +$3.63K 1.06% 29
2022
Q3
$4.31M Buy
26,366
+146
+0.6% +$24.7K 1.07% 29
2022
Q2
$4.65M Sell
26,220
-222
-0.8% -$39.6K 1.08% 29
2022
Q1
$4.69M Buy
26,442
+165
+0.6% +$28.1K 0.94% 37
2021
Q4
$4.5M Hold
26,277
0.87% 35
2021
Q3
$4.24M Hold
26,277
0.89% 35
2021
Q2
$4.33M Sell
26,277
-30
-0.1% -$4.97K 0.9% 37
2021
Q1
$4.32M Buy
26,307
+202
+0.8% +$32.7K 0.96% 33
2020
Q4
$4.11M Buy
26,105
+58
+0.2% +$8.56K 0.99% 32
2020
Q3
$3.88M Sell
26,047
-882
-3% -$131K 1.06% 29
2020
Q2
$3.79M Buy
26,929
+10,598
+65% +$1.54M 1.14% 27
2020
Q1
$2.14M Buy
16,331
+5,333
+48% +$757K 0.78% 36
2019
Q4
$1.55M Hold
10,998
0.49% 41
2019
Q3
$1.42M Hold
10,998
0.49% 45
2019
Q2
$1.53M Hold
10,998
0.54% 45
2019
Q1
$1.54M Buy
10,998
+2
+0% +$268 0.58% 41
2018
Q4
$1.42M Buy
10,996
+3
+0% +$418 0.61% 42
2018
Q3
$1.52M Buy
10,993
+3
+0% +$399 0.56% 47
2018
Q2
$1.33M Buy
10,990
+3
+0% +$374 0.53% 47
2018
Q1
$1.41M Buy
10,987
+2
+0% +$270 0.57% 47
2017
Q4
$1.53M Buy
10,985
+2,503
+30% +$349K 0.61% 43
2017
Q3
$1.1M Buy
8,482
+2
+0% +$265 0.5% 55
2017
Q2
$1.12M Buy
8,480
+1,269
+18% +$162K 0.53% 55
2017
Q1
$898K Buy
7,211
+3
+0% +$358 0.45% 59
2016
Q4
$830K Buy
7,208
+3
+0% +$347 0.47% 60
2016
Q3
$851K Buy
7,205
+2
+0% +$243 0.46% 61
2016
Q2
$874K Buy
7,203
+3
+0% +$341 0.48% 61
2016
Q1
$779K Buy
7,200
+3,785
+111% +$392K 0.46% 62
2015
Q4
$351K Hold
3,415
0.23% 64
2015
Q3
$319K Hold
3,415
0.23% 63
2015
Q2
$333K Sell
3,415
-288
-8% -$28.8K 0.22% 64
2015
Q1
$373K Hold
3,703
0.25% 62
2014
Q4
$387K Hold
3,703
0.27% 62
2014
Q3
$395K Hold
3,703
0.28% 62
2014
Q2
$387K Sell
3,703
-67
-2% -$6.77K 0.26% 62
2014
Q1
$370K Buy
3,770
+155
+4% +$14.4K 0.26% 60
2013
Q4
$331K Buy
+3,615
New +$333K 0.24% 62

Other funds holding JNJ

Blue Edge Capital's JNJ Position: Q1 2026 in Review

Blue Edge Capital increased its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, buying an estimated $473K and bringing the position to 18,533 shares worth $4.53M. The position accounts for 0.6% of the portfolio, ranked #45.

Blue Edge Capital first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.69M in Q1 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Blue Edge Capital held 18,533 shares of Johnson & Johnson worth $4.53M as of Q1 2026.
  • Blue Edge Capital bought 2,029 Johnson & Johnson shares in Q1 2026, an estimated $473K.
  • Johnson & Johnson made up 0.6% of Blue Edge Capital's portfolio in Q1 2026, its #45 holding.
  • Blue Edge Capital first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • Blue Edge Capital's Johnson & Johnson position peaked at $4.69M in Q1 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Blue Edge Capital's 13F filing for Q1 2026, filed 2 Jun 2026.